Business Description
Moderna Inc
NAICS : 325412
SIC : 2836
ISIN : US60770K1079
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.69 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.34 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 4.09 | |||||
Beneish M-Score | -3.56 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 190.8 | |||||
3-Year EBITDA Growth Rate | -64.8 | |||||
3-Year EPS without NRI Growth Rate | -83.9 | |||||
3-Year Book Growth Rate | 78.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 21.57 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 0.04 | |||||
9-Day RSI | 1.72 | |||||
14-Day RSI | 7.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.09 | |||||
Quick Ratio | 3.92 | |||||
Cash Ratio | 3.59 | |||||
Days Inventory | 45.3 | |||||
Days Sales Outstanding | 48.15 | |||||
Days Payable | 38.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.4 | |||||
Shareholder Yield % | -0.89 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 32.22 | |||||
Operating Margin % | -92.92 | |||||
Net Margin % | -117.62 | |||||
FCF Margin % | -79.77 | |||||
ROE % | -42.65 | |||||
ROA % | -31.83 | |||||
ROIC % | -64.09 | |||||
3-Year ROIIC % | -95.6 | |||||
ROC (Joel Greenblatt) % | -159.22 | |||||
ROCE % | -27.98 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.12 | |||||
PB Ratio | 1.76 | |||||
Price-to-Tangible-Book | 1.78 | |||||
EV-to-EBIT | -3.11 | |||||
EV-to-Forward-EBIT | -3.96 | |||||
EV-to-EBITDA | -3.55 | |||||
EV-to-Forward-EBITDA | -4.48 | |||||
EV-to-Revenue | 2.68 | |||||
EV-to-Forward-Revenue | 3.92 | |||||
EV-to-FCF | -3.38 | |||||
Price-to-Projected-FCF | 0.52 | |||||
Price-to-Net-Current-Asset-Value | 3.63 | |||||
Price-to-Net-Cash | 4.57 | |||||
Earnings Yield (Greenblatt) % | -32.14 | |||||
FCF Yield % | -19.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Moderna Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil лв) | 9,034.216 | ||
EPS (TTM) (лв) | -27.856 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 7.6 | ||
14-Day ATR (лв) | 0.059281 | ||
20-Day SMA (лв) | 111.6 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (лв) | 109.06 - 149.5 | ||
Shares Outstanding (Mil) | 384.4 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Moderna Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Moderna Inc Stock Events
Event | Date | Price(лв) | ||
---|---|---|---|---|
No Event Data |
Moderna Inc Frequently Asked Questions
What is Moderna Inc(XBUL:0QF)'s stock price today?
When is next earnings date of Moderna Inc(XBUL:0QF)?
Does Moderna Inc(XBUL:0QF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |